A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

1,208

Participants

Timeline

Start Date

August 19, 2022

Primary Completion Date

January 23, 2023

Study Completion Date

March 21, 2023

Conditions
COVID-19
Interventions
DRUG

SIM0417

dose of 750 mg SIM0417 with 100 mg ritonavir.

DRUG

Placebo

Placebo (tablet)

Trial Locations (35)

Unknown

Hefei First People's Hospital, Hefei

Beijing Ditan Hospital Captial Medical University, Beijing

Chongqing Public Health Medical Center, Chongqing

The First Affiliated Hospital of Xiamen University, Xiamen

Guangzhou Eighth People's Hospital Guangzhou Medical University, Guangzhou

Maoming People's Hospital, Maoming

Qingyuan People's Hospital, Qingyuan

The Third People's Hospital of Shenzhen, Shenzhen

Central People's Hospital of Zhanjiang, Zhanjiang

The Fifth Affiliated Hospital Sun Yat-Sen University, Zhuhai

GuiZhou Province People's Hospital, Guiyang

Haikou people's Hospital, Haikou

Hainan Third People's Hospital, Sanya

Mudanjiang Kangan Hospital, Mudanjiang

Wuhan Jinyintan Hospital, Wuhan

The First Hospital of Changsha, Changsha

The Second Hospital of Nanjing, Nanjing

ZhongDa Hospital SouthEast University, Nanjing

The Fifth People's Hospital of Suzhou, Suzhou

Taizhou People's Hospital, Taizhou

Wuxi No.5 People's Hospital, Wuxi

Xuzhou Infectious Disease Hospital, Xuzhou

Subei People's Hospital of Jiangsu province, Yangzhou

The Third People's Hospital of Zhenjiang, Zhenjiang

The First Affiliated Hospital of Nanchang University, Nanchang

The Sixth People's Hospital of ShenYang, Shenyang

Shandong Public Health Clinical Center, Jinan

Shanghai Public Health Clinical Center, Shanghai

Public health clinical center of Chengdu, Chengdu

Suining Central Hospital, Suining

Tianjin first center hospital, Tianjin

Affliated Hangzhou XiXi Hospital Zhejiang University School of Medicine, Hangzhou

Huzhou Central Hospital, Huzhou

HwaMei Hospital University of Chinese Academy of Sciences, Ningbo

Wenzhou Central Hospital, Wenzhou

All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY